Diabetes 56:2124-2134, 2007 DOI: 10.2337/db07-0030 © 2007 by the American Diabetes Association
The Actions of a Novel Potent Islet ß-Cell–Specific ATP-Sensitive K+ Channel Opener Can Be Modulated by Syntaxin-1A Acting on Sulfonylurea Receptor 1
1 Departments of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada Address correspondence and reprint requests to Herbert Y. Gaisano, Room 7226 Medical Science Building, University of Toronto, Toronto, Ontario, Canada M5S 1A8. E-mail: herbert.gaisano{at}utoronto.ca
Abbreviations:
EC50, half-maximal effective concentration; KATP, ATP-sensitive K+ channel; GFP, green fluorescence protein; GST, glutathione S-transferase; IKATP, ATP-sensitive K+ current; NNC55-0462, 6-chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide; SNARE, soluble N-ethylmaleimide–sensitive factor attachment protein receptor; SUR, sulfonylurea receptor
Islet ß-cell–specific ATP-sensitive K+ (KATP) channel openers thiadiazine dioxides induce islet rest to improve insulin secretion, but their molecular basis of action remains unclear. We reported that syntaxin-1A binds nucleotide binding folds of sulfonylurea receptor 1 (SUR1) in ß-cells to inhibit KATP channels. As a strategy to elucidate the molecular mechanism of action of these KATP channel openers, we explored the possibility that 6-chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (NNC55-0462) might influence syntaxin-1A–SUR1 interactions or vice versa. Whole-cell and inside-out patch-clamp electrophysiology was used to examine the effects of glutathione S-transferase (GST)-syntaxin-1A dialysis or green fluorescence protein/syntaxin-1A cotransfection on NNC55-0462 actions. In vitro pull-down binding studies were used to examine NNC55-0462 influence on syntaxin-1A–SUR1 interactions. Dialysis of GST–syntaxin-1A into the cell cytoplasm reduced both potency and efficacy of extracellularly perfused NNC55-0462 in a HEK cell line stably expressing Kir6.2/SUR1 (BA8 cells) and in rat islet ß-cells. Moreover, inside-out membrane patches excised from BA8 cells showed that both GST–syntaxin-1A and its H3 domain inhibited KATP channels previously activated by NNC55-0462. This action on KATP channels is isoform-specific to syntaxin-1A because syntaxin-2 was without effect. Furthermore, the parent compound diazoxide showed similar sensitivity to GST–syntaxin-1A inhibition. NNC55-0462, however, did not influence syntaxin-1A–SUR1 binding interaction. Our results demonstrated that syntaxin-1A interactions with SUR1 at its cytoplasmic domains can modulate the actions of the KATP channel openers NNC55-0462 and diazoxide on KATP channels. The reduced levels of islet syntaxin-1A in diabetes would thus be expected to exert a positive influence on the therapeutic effects of this class of KATP channel openers.
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||